Welcome to CDC Stacks | Extensively drug-resistant tuberculosis; (XDR TB) - 5882 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Extensively drug-resistant tuberculosis; (XDR TB)
  • Published Date:
    February 2009
Filetype[PDF - 326.24 KB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
  • Series:
    TB elimination
  • Description:
    "Extensively drug-resistant tuberculosis (XDR TB) is a relatively rare type of multidrug-resistant tuberculosis (MDR TB). It is resistant to almost all drugs used to treat TB, including the two best first-line drugs: isoniazid and rifampin. XDR TB is also resistant to the best second-line medications: fluoroquinolones and at least one of three injectable drugs (i.e., amikacin, kanamycin, or capreomycin). (World Health Organization [WHO] definition for cases detected on initial susceptibility testing.)." - p. 1

  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Place as Subject:
    United States
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Extensively drug-resistant tuberculosis; (XDR TB)
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published:
    January 2013
    Series:
    TB elimination
    Description:
    Extensively drug resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin...
    File Type:
    Filetype[PDF - 421.42 KB]
  2. CDC's role in preventing extensively drug-resistant tuberculosis (XDR TB); (XDR TB)
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published:
    February 2013
    Series:
    TB elimination
    Description:
    The Centers for Disease Control and Prevention (CDC) is collaborating with other federal agencies and international partners to raise awareness and enhance strategies for TB prevention worldwide by: Strengthening TB services for people living with; A...
    File Type:
    Filetype[PDF - 409.80 KB]
  3. Investigation of U.S. traveler with extensively drug resistant tuberculosis (XDR TB)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    5/29/07
    Source:
    HAN ; 261
    Series:
    HAN ; 261
    Description:
    Tuesday, May 29, 2007, 0:40 EDT (12:40 PM EDT) : CDCHAN-00261-2007-05-29-ADV-N : The Centers for Disease Control and Prevention (CDC) is working with a number of international, state, and local partners on an investigation involving a U.S. citizen re...
    File Type:
    Filetype[PDF - 29.55 KB]
  4. Corrected : Investigation of U.S. traveler with extensively drug resistant tuberculosis (XDR TB)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    5/29/07
    Source:
    HAN ; 262
    Series:
    HAN ; 262
    Description:
    Tuesday, May 29, 2007, 15:30 EDT (03:30 PM EDT) : CDCHAN-00262-2007-05-29-UPD-N : This message is being sent to correct the flight number of the Czech Air flight on May 24, 2007 from Prague, Czech Republic to Montreal, Canada. The flight number was 0...
    File Type:
    Filetype[PDF - 32.73 KB]
  5. Extensively Drug-Resistant Tuberculosis, Pakistan
    Personal Author:
    Hasan, Rumina; Jabeen, Kauser; Ali, Asho; Rafiq, Yasraba; Laiq, Rabia; Malik, Babar; Tanveer, Mahnaz; Groenheit, Ramona; Ghebremichael, Solomon; Hoffner, Sven; Hasan, Zahra;
    Published:
    Sep 2010
    Source:
    Emerg Infect Dis. 16(9):1473-1475.
    Description:
    Frequency of extensively drug-resistant tuberculosis in Pakistan increased from 1.5% in 2006 to 4.5% in 2009 (p<0.01). To understand the epidemiology, we genotyped selected strains by using spoligotyping, mycobacterial interspersed repetitive units-v...
    File Type:
    Filetype[PDF - 136.24 KB]